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Abstract:  Background:  Despite  the  role  of  metacognition  in 
psychopathology,  no  studies  have  explored  this  construct  in  the  area  of 
gastrointestinal  disorders.  Moreover,  for  many  times  there  was  a 
categorization  between  organic  and  functional  gastrointestinal  disorders. 
The aim of this study was to compare dysfunctional metacognitive beliefs 
between patients with functional bowel disorders and patients with organic 
bowel disorders. The purpose of this work was also to examine the relations 
between metacognitions, alexithymia and symptoms of the patients on the 
basis of diagnosis. 
Methods: A between-subject non parametric and correlational design was 
employed. We formed three clinical groups from a population of patients 
with  gastrointestinal  disorders  and  on  the  basis  of  the  ‘organic’  and 
‘functional’ diagnosis. All the participants underwent the Metacognitions 
Questionnaire  30,  the  Toronto  Alexithymia  Scale-20  and  the 
Gastrointestinal Symptom Rating Scale. 
Results: There were no significant differences between the three clinical 
groups on MCQ-30 and TAS-20 scores. However, there were significant 2      QUATTROPANI MC., LENZO V.,   ET AL. 
correlations  based  on  diagnosis  of  the  gastrointestinal  disorder  between 
alexithymic features and metacognitive dysfunctional beliefs. 
Conclusions:  Our  results  underline  the  role  of  metacognitions  for  both 
patients with organic and functional gastrointestinal disorders. Moreover, 
the results highlight the importance to consider these aspects in patients with 
organic gastrointestinal disorder. 
 
Keywords: alexithymia; Crohn’s disease; IBS;  metacognition; ulcerative 
colitis.   
 
 
INTRODUCTION 
In recent years, the high prevalence, the health care and social costs, 
and the impact on the patients of the symptoms of gastrointestinal disorders 
have increased the mole of empirical research on gastrointestinal disorders. 
However, attempts to identify specific categories through specific cluster of 
symptoms  have  not  showed  good  results  because  there  is  an  overlap 
between various subgroups of gastrointestinal disorders, such as those and 
other  aspecific  syndromes.  In  this  field  of  research,  the  diagnostic 
distinction between ‘functional’ and ‘organic’ (Prasko, Jelenova, & Mihal, 
2010) shows many limits in the possibility to offer efficacious therapeutic 
strategies.  Currently,  Rome  II  survey  criteria  (Drossman,  2006)  are 
guidelines to the diagnosis of functional gastrointestinal disorders, which 
include  the    irritable  bowel  syndrome  (IBS).  The  symptoms  of 
gastrointestinal disorders cause a strong impairment in daily function and 
they affect health-related quality of life, work absenteeism, health care use, 
and  high  medical  costs  (Gralnek,  Hays,  Kilbourne,  Naliboff,  &  Mayer, 
2000; Portincasa, Moschetta, Baldassarre, Altomare, & Palasciano, 2003; 
Moser, 2006). However, in the field of the medical research there is a lack 
of  evidence  of  pharmacological  agents  licensed  specifically  for  the 
treatments of IBS subtypes. More general, evidences for the efficacy, safety 
and tolerability of therapies for IBS are still limited (Tack, Fried, Houghton, 
Spicak,  &  Fisher,  2006).  Further,  the  gastrointestinal  problems  are 
associated with the presence of emotional distress (Porcelli, 2004). In the 
last two decades, some authors have examined possible links between IBS 
and  psychopathology  (Thornton,  McIntyre,  Murray-Lyon,  &  Gruzelier, 
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According to this point of view, a more recent research has indicated 
an  association  between  unexplained  chronic  gastrointestinal 
symptomatology  and  psychiatric  disorders  such  as  depression  or  anxiety 
disorder in a sample of young adults (Howell, Poulton, Caspi, & Talley, 
2003). 
In the last years, the weight of psychosocial factors on the symptoms 
relating to the onset and the course of the illness are more than in the past 
(Surdea-Blaga, Băban, & Dumitrascu, 2012).  
In the literature, the efficacy of a psychological treatment to decrease 
the anxiety levels in patients with IBS has been demonstrated (Bennett, & 
Wilkinson, 1985) and the anxiety level was a better individual predictor of 
outcome  from  a  variety  of  psychological  and  psychosocial  aspects 
(Blanchard, Schwarz, Neff, & Gerardi, 1988). However, many studies have 
showed that an integrated psychological and medical approach increases the 
efficacy of the treatments (Heymann-Monikes et al., 2000).  
In  the  clinical  practice  of  ‘organic’  gastrointestinal  disorders,  the 
Inflammatory Bowel Diseases (IBD) are ulcerative colitis (UC) and Crohn’s 
disease  (CD),  as  well  as  indeterminate  colitis.  Both  UC  and  CD  need 
specific  pharmacologic  agents  and  often  surgical  interventions,  both 
associated with a severe impairment on quality of life of subjects.  
Although these diseases are classified as ‘organic’, in recent years 
some  studies  have  explored  the  psychological  aspects.  A  review  (Graff, 
Walker,  &  Bernstein,  2009)  has  highlighted  that  patients  with  IBD  very 
often have anxiety and depression and that these psychological symptoms 
are more severe during the periods of active phase of disease. Furthermore, 
the  results  in  this  area  of  research  have  found  a  significant  association 
between  anxious  and  avoidant  attachment  styles  and  severity  of  the 
‘organic’ gastrointestinal disorders (Gick & Sirois, 2010; Agostini et al., 
2010).  
A recent study on a clinical sample of 534 patients with IBD has 
found a highly prevalence of alexithymia  and an association with a very 
impaired quality of life (Iglesias-Rey et al., 2012).  
With regard of alexithymia construct, several empirical studies has 
shown  that  alexithymic  patients  find  it  hard  to  distinguish  that  physical 
sensations are sometimes the somatic concomitants of affect (Kooiman et 
al., 2000). 
The  ancient  vision  of  the  bowel  as  a  secondary  and  peripheral 
structure of the organism has changed in the last years (Gershon, 1999). 
Moreover, evidences from many field of the research have showed a more 4      QUATTROPANI MC., LENZO V.,   ET AL. 
complex vision of the human organism than in the past. These results led us 
to argue that psychosocial aspects can play an important role also in the 
organic gastrointestinal disorders. 
In light of these findings, several studies have attempted to examine 
the  role  of  psychosocial  variables  both  in  the  organic  and  functional 
gastrointestinal  disorders.  Recently,  Tkalcic,  Hauser  &  Stimac  (2010) 
compared  the  quality  of  life,  the  affective  state  and  the  personality  in 
patients with IBS and patients with IBD. Results showed that trait anxiety 
and nevroticism, as personality traits, are higher in patients with IBS than 
IBD, even if patients with IBD are more impaired in the physical aspects of 
quality of life than others. Moreover, the nevroticism, as personality trait, 
predicted the emotional distress of the patients with IBS.  
Therefore, these results indicate the importance to study in depth the 
psychological  aspects  in  the  ‘organic’  disorders.  These  psychological 
aspects  can  play  a  role  also  in  the  possibility  to  have  more  efficacious 
psychological treatments for these patients. 
Although  there  is  much  evidence  pointing  towards  the  role  of 
psychological  constructs  as  anxiety,  depression,  alexithymia,  coping 
strategy,  defense  mechanisms,  no  studies  have  examined  the  role  of 
metacognitions in the field of gastrointestinal disorders.  
Regarding the role of the metacognitions, many lines of evidence 
indicate  that  there  is  a  strong  relationship  between  emotion  processes, 
cognitions,  metacognitive  beliefs  and  behaviors  (Brune,  2006),  also  for 
patients with gastrointestinal disorders (Aszalos, 2008). In fact, according to 
Wells and Matthews (1994, 1996) dysfunctional metacognitive beliefs are 
the basis for the development and maintenance of psychological disorders.  
Results in this area of empirical research show relationships between 
dysfunctional metacognitive beliefs and generalized anxiety disorder (Wells 
& Carter, 2001; Wells, 2007; Tan, Moulding, Nedeljkovic & Kyrios, 2010), 
social phobia (Wells & Carter, 2001; Wells, 2007), panic disorder (Wells & 
Carter,  2001;  Wells,  2007),  obsessive-compulsive  disorder  (Wells  & 
Papageorgiou,  1998;  O'Leary,  Rucklidge,  &  Blampied,  2009;  Rees  & 
Anderson, 2013), worry in a non-clinical population (Khawaja & Chapman, 
2007), hallucination-prone subjects (Larøi, Van der Linden, & Marczewski, 
2004),  predisposition  to  hallucinations  (García-Montes,  Cangas,  Pérez-
Álvarez, Fidalgo, & Gutiérrez, 2006), anorexia nervosa (Cooper, Grocutt, 
Deepak,  &  Bailey,  2007),  patients  with  schizophrenia  before  hospital 
discharge  (Giusti,  Mazza,  Pollice,  Casacchia  &  Roncone,  2013), 
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patients  with  severe  auditory  verbal  hallucinations  (van  Oosterhout, 
Krabbendam,  Smeets,  &  van  der  Gaag,  2012),  distress  associated  with 
auditory  verbal  hallucinations  (Hill,  Varese,  Jackson,  &  Linden,  2012), 
stress sensitization in individuals at ultra-high risk of developing psychosis 
(Palmier-Claus, Dunn, Taylor, Morrison, & Lewis, 2013). 
According to Wells and Purdon’s definition (1999), metacognition is 
“the  aspect  of  information  processing  that  monitors,  interprets,  evaluates 
and regulates the contents and processes of its organization”.  
By this point of view, we hypothesized that metacognitions would 
play  an  important  role  in  both  organic  and  functional  gastrointestinal 
disorders.  In  this  study,  we  aimed  to  investigate  the  presence  of 
dysfunctional  metacognitive  beliefs  in  patients  with  gastrointestinal 
disorders.  Moreover,  we  compared  the  metacognitive  beliefs  in  three 
clinical groups on the basis of distinction between ‘organic’ and functional 
and  of  the  IBS  or  IBD’s  diagnosis.  Another  aim  of  this  study  was  to 
examine the associations between dysfunctional metacognitive beliefs and a 
more studied construct that is alexithymia. 
 
Materials and methods 
Subjects 
Sixty-five  outpatients  of  the  Clinical  Unit  for  Chronic  Bowel 
Disorders of the Department of Internal Medicine, Policlinico Universitario 
of  Messina,  were  consecutively  selected  after  an  assessment  by  a 
gastroenterologist according to IBS, UC or CD diagnosis. Afterwards, all 
patients underwent a clinical interview conducted by a clinical psychologist 
with five years of clinical experiences in this field of research to exclude the 
presence of: positive anamnesis for schizophrenia or severe somatization 
disorders, any psychiatric disorder included in Axis I and/or Axis II of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR; APA, 
2000) at the time of gastrointestinal diagnosis or during a six-month period 
prior the study. On the basis of these criterions, we excluded four patients. 
Afterwards,  all  patients  were  given  a  brief  clinical  interview  to 
evaluate socio-demographic features and then the battery of tests of this 
study. Before to their participation in the study, all participants gave written 
consent. 
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Measures 
All the patients underwent the following test: 
- Metacognition Questionnaire-30  (MCQ-30; Wells & Cartwright-Hatton, 
2004). The MCQ-30 is a 30 item self-report questionnaire, which measures 
a range of metacognitive beliefs and processes relevant to vulnerability and 
maintenance of emotional disorders. The items are rated on a 4-point Likert 
scale  from  1  (‘do  not  agree’)  to  4  (‘completely  agree’).  The  items  are 
grouped into five subscales, as in the original version (Cartwright-Hatton & 
Wells,  1997).  Factorial  analysis  has  shown  the  presence  of  five  factor 
(Wells & Cartwright-Hatton, 2004):  cognitive confidence, which measures 
confidence in attention and memory (Cognitive confidence, CC); cognitive 
self-consciousness,  which  measures  the  tendency  to  monitor  one’s  own 
thoughts  and  focus  attention  inward  (Cognitive  self-consciouness,  CS); 
positive beliefs about worry, which measures the extent to which a person 
thinks that perseverative thinking is useful (Positive beliefs, PB); negative 
beliefs about worry concerning uncontrollability and danger, which assess 
the  extent  to  which  a  person  thinks  that  perseverative  thinking  is 
uncontrollable and dangerous (Uncontrollability and danger, UD); beliefs 
about the need to control thoughts, which assesses the extent to which a 
person believes that certain types of thoughts need to be suppressed (Need 
to control thoughts, NCT).  
The  MCQ-30  is  a  brief,  reliable  and  valid  self-report  measure  of 
metacognitions (Wells & Cartwright-Hatton, 2004; Spada, Mohiyeddini, & 
Wells, 2008). In this study, Cronbach’s alpha coefficients are: Cognitive 
confidence, Cronbach’s α = .87;  Cognitive self-consciouness, Cronbach’s α 
= .71; Positive beliefs, Cronbach’s α = .85; Uncontrollability and danger, 
Cronbach’s α = .82; Need to control toughts,  Cronbach’s α = .75). 
- Toronto Alexithymia Scale-20 (TAS-20;  Taylor, Bagby, & Parker, 1994a, 
1994b;  Bressi  et  al.,  1996).  The  TAS-20  is  a  20  item  self-report 
questionnaire, which measures the presence of alexithymia. The items are 
rated on a 5-point Likert scale ranging from 1 (‘strongly disagree’) to 5 
(‘strongly agree’). The items are clustered into three factors corresponding 
to  the  theoretical  dimensions  of  alexithymia:  difficulty  in  identifying 
feelings  and  distinguishing  between  feelings  and  somatic  sensations  of 
emotional arousal (F1: DIF); difficulty in describing feeling to others (F2: 
DDF); externally-oriented thinking (F3: EOT). Total scores ranging from 20 
to 100. The TAS-20 has demonstrated good psychometric properties and it 
is  currently  the  most  widely  used  measure  of  the  alexithymia  construct  
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-   Gastrointestinal  Symptom  Rating  Scale  (GSR;  Svedlund,  Dotevall,  & 
Sjodin, 1998; Kulich et al., 2004). The GSRS is an observer-rated illness-
specific questionnaire. The scale includes 15 symptoms rated on a 4-point 
Likert  scale  ranging  from  0  (which  denotes  no  symptoms)  to  3  (which 
denotes  the  most  pronounced  symptoms)  and  measures.  The  total  score 
represents overall frequency and severity of gastrointestinal symptoms and 3 
subscale scores correspond to dyspeptic (DYS; epigastric pain, squeezing 
sensations,  acid  regurgitation,  heartburn,  and  nausea),  digestive  (DIG; 
borborygmus, abdominal distension, eructation, and increased flatus) and 
intestinal  (INT;	 ﾠ decreased  passage  of  stools,  increased  passage  of  stools, 
loose  stools,  hard  stools,  urgent  need  of  defecation,  and  feeling  of 
incomplete evacuation) syndromes. The GSRS is well-validated and used 
widely in gastrointestinal research (Wiklund, 1993). 
 
Statistical analysis 
Data  obtained  from  the  research  underwent  check  and,  subsequently,  to 
descriptive  and  inferential  statistical  analysis.  Subsequently,  we  applied 
non-parametric test for three independent samples. Continuous data were 
expressed as mean ± DS and significant differences between clinical groups 
was  appraised  using  the  Kruskal-Wallis  non-parametric  test  for  three 
independent samples. 
Non  continuous  data  were  expressed  as  percentages  and  the  comparison 
between groups was performed  by using the χ
2-test. The significance level 
for the test was p < 0.01. 
Spearman correlation coefficients were calculated to examine the bivariate 
associations between dysfunctional metacognitive beliefs and alexithymic 
features. The significance levels for the correlation coefficients was p < 0.05 
and p < 0.001.  
The  statistical  analysis  was  performed  with  Statistical  Package  for  the 
Social Sciences v.18 software (SPSS Inc, 2009). 
 
 
Results  
Clinical groups features 
The sample of patients with IBS and functional bowel disorder consisted of 
20 individuals (11 males; 9 females) between 18 and 76 years of age (mean 
age: 39.3; DS: 19.8). The duration of disease varied from a minimum of 1 
month to a maximum of 30 years (mean duration in years: 3.81; DS: 6.63; 
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The  sample  of  patients  with  UC  and  organic  gastrointestinal  disorder 
consisted of 20 individuals (10 males; 10 females) between 21 and 62 years 
of age (mean age: 37.32; DS: 12.71). The duration of disease varied from a 
minimum of 2 months to a maximum of 35 years (mean duration in years: 
7.47; DS: 10.07; median in years: 2.42). 
The sample of outpatients with CD and organic bowel disorder consisted of 
19 individuals (12 males; 7 females) between 21 and 68 years of age (mean 
age: 39.84; DS: 14,46). The duration of disease varied from a minimum of 1 
month to a maximum of 35 years (mean duration in years: 11.21; DS: 9.26; 
median in years: 10). 
Regarding  social  and  demographic  features,  there  were  no  significant 
differences  between  the  three  clinical  groups  (Table  1).  The  social  and 
demographic  features  did  not  affect  the  subsequently  comparison  of  the 
three clinical groups. 
 
Table  1.  Descriptive  statistics  (mean  with  standard  deviations  in  parentheses)  of  socio-
demographic features of IBS, UC and CD patients 
  IBS  UC  CD  Kruskal-
Wallis test (d.f. 2) 
M (DS)  M (DS)  M (DS)  H  p 
Age (years)  39.30 (19.80)  37.32 
(12.71) 
39.84 
(14.46) 
4.610  .100 
Level  of  education 
(years) 
12.25 (3.73)  11.91 (4.71)  10.95 (4.64)  1.065  .587 
  Chi-Square 
(d.f. 4) 
Marital status (%)        χ2  p 
Single  55  36.36  47     
Married  45  54.55  53     
Widower  -  9.09  -  1.63  .804 
Divorced  -  -  -     
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Group differences (Kruskal-Wallis non-parametric test) 
Tables 2,3 e 4 show descriptive statistics and results of the Kruskal-
Wallis non-parametric test for three independent samples for IBS, UC and 
CD patients. As can be seen in tables, there were no significant differences 
for the variables in the three clinical groups. 
 
 
Table 2. MCQ mean scores (with standard deviations in parentheses) and group differences of IBS, UC and CD 
patients 
Scale 
IBS  UC  CD  Kruskal-Wallis  test 
(d.f 2) 
M (DS) 
M 
(DS) 
M (DS)  H  p 
Cognitive Confidence  12.25 (4.61) 
13.05 
(5.33) 
14,47 (5.35)  1.791  .408 
Cognitive Self-consciouness  18.25 (2.45) 
17.64 
(2.70) 
17,53 (2.74)  0.852  .653 
Positive Beliefs  10.40 (4.90) 
11.50 
(4.50) 
10,68 (4.87)  1.297  .523 
Uncontrollability and Danger  13.65 (3.73) 
14.73 
(4.29) 
15,37 (4.92)  1.231  .540 
Need to control toughts  13.15 (3.15) 
14.45 
(4.68) 
15.42  (4.55)  2.929  .231 
Notes: scores have been compared by Kruskal-Wallis H-test for two independent samples. 
 
Table 3. TAS-20  mean scores (with standard deviations in parentheses)  and group differences of IBS, UC and 
CD patients 
Factor 
IBS  UC  CD  Kruskal-Wallis test (d.f. 2) 
M (DS)  M (DS)  M (DS)  H  p 
F1  19.55 (7.40)  15.95 (6.79)  18.63 (8.64)  2.676  .262 10      QUATTROPANI MC., LENZO V.,   ET AL. 
F2  11.90 (5.23)  14.14 (5.46)  13.47 (5.11)  1.914  .384 
F3  17.45 (3.66)  18.86 (5.08)  19.00 (4.90)  1.536  .436 
TOT  48.90 (5.43)  48.95 (5,77)  51.10 (6.22)  0.331  .848 
Notes: scores have been compared by Kruskal-Wallis H-test for two independent samples. 
F1 = difficulty in identifying feelings and distinguishing between feelings and somatic sensations of emotional 
arousal; F2 = difficulty in describing feeling to others; F3 = externally-oriented thinking. 
 
 
 
 
Table 4. GSRS mean scores (with standard deviations in parentheses) and group differences of IBS, UC and 
CD patients 
 
IBS  UC  CD  Kruskal-Wallis test (d.f. 
2) 
M (DS)  M (DS)  M (DS)  H  p 
DYS  63.45 (22.85)  65.68 (18.06)  69.05 (19.66)  1.042  .594 
DIG  97.55 (44.54)  98.36 (32.57) 
105.63 
(35.85) 
0.614  .736 
INT  212.55 (90.74)  215.59 (66.04) 
230.00 
(72.64) 
0.645  .724 
TOT  234.85 (89.65)  241.23 (67.91) 
254.42 
(73.36) 
0.872  .647 
Notes: scores have been compared by Kruskal-Wallis H-test for two independent samples. 
DYS = dyspeptic symptoms; DIG = digestive symptoms; INT = intestinal symptoms; TOT = global score 
GSRS. 
 
 
 
Correlational analysis (Rhos ) 
As can be seen in Table 5, the results of correlational analysis regarding the 
three clinical groups show significant associations between MCQ-30 and 
TAS-20. 
Regarding  clinical  group  with  IBS,  Cognitive  Confidence  subscale  was 
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feelings  and  distinguishing  between  feelings  and  somatic  sensations  of 
emotional arousal of TAS-20 (r = .51; p < .05). Moreover, there was a 
negatively correlation between DIF subscale of TAS-20 and the Need to 
control thoughts scale  of MCQ-30 (r = -.48; p < .05). The NCT scale of 
MCQ-30 was also negatively correlated with EOT subscale – Externally-
oriented thinking (r = -.44; p < .05). 
Regarding clinical group with CD, there was an highly positive correlation 
between  Cognitive Confidence subscale of MCQ-30 and DIF subscale - 
Difficulty  in  identifying  feelings  and  distinguishing  between  feelings  and 
somatic  sensations  of  emotional  arousal  (r  =  .72;  p  <  .001).  The  DIS 
subscale  showed  a  positively  correlation  with  the  Uncontrollability  and 
Danger of MCQ-30 (r = .49; p < .05). 
Regarding clinical group with UC, there were not significant coefficients 
correlation between MCQ-30 and TAS-20. 
 
 
 
 
Table 5. Correlational analysis between MCQ-30 and TAS-20 of IBS, UC and CD patients 
  TAS-20 F1  TAS-20 F2  TAS-20 F3 
IBS  UC  CD  IBS  UC  CD  IBS  UC  CD 
MCQ-30 
CC 
.51*  0.28  .72**  0.35  0.26  0.43  0.23  0.02  0.15 
MCQ-30 
CS 
-0.30  0.18  0.12  0.01  -0.01  -0.03  0.06  -0.27  -0.31 
MCQ-30 
PB 
0.04  0.25  0.24  -0.08  0.30  -0.05  -0.11  0.07  0.07 
MCQ-30 
UD 
0.07  0.27  .49*  0.27  0.13  0.35  0.29  0.12  0.19 
MCQ-30 
NCT 
-.48*  0.41  0.37  -0.31  0.38  0.25  -.44*  0.04  0.27 
Notes: CC = Cognitive Confidence; CS = Cognitive Self-Consciousness; PB = Positive Beliefs; UD = 
Uncontrollability  and  Danger;  NCT  =  Negative  Control  Thoughts;  F1  =  difficulty  in  identifying 
feelings  and  distinguishing  between  feelings  and  somatic  sensations  of  emotional  arousal;  F2  = 
difficulty in describing feeling to others; F3 = externally-oriented thinking. 
*p < .05; **p < .001. 
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Discussion 
The current study aimed to explore the role of metacognitions in the field of 
gastrointestinal  disorders  where  there  was  for  many  years  a  distinction 
between ‘organic’ and ‘functional’. 
Patients  with  an  ‘organic’  diagnosis  were  often  approached  by 
gastroenterologists    in  a  different  way  from  patients  with  a  ‘functional’ 
diagnosis. With regard to the course of the gastrointestinal disorder, it might 
influences the illness experience of disease and the efficacy of treatments. 
Moreover,  there  was  a  lack  of  studies  that  had  explored  metacognitive 
beliefs  of  these  patients,  even  so  metacognitions  are  the  basis  for  the 
development  and  maintenance  of  clinical  problems.  According  to  us, 
differences  between  patients  with  different  diagnosis  of  gastrointestinal 
disorders can depend by other factors as the severity and duration of the 
disorder, periods of acute symptom exacerbation or psychological features 
of the subjects. 
In the past, psychological aspects in the organic gastrointestinal disorders 
had  a  lower  weight  than  in  the  functional  gastrointestinal  disorders. 
Furthermore, there was a vision of bowel as a secondary and peripheral 
structure  of  the  organism.  In  contrast,  the  psychosomatic  research 
attempted to clarify the role of psychosocial features relating to the onset 
and the course of the illness and symptoms of functional gastrointestinal 
disorders with less attention to the organic disorders. 
It is very hard for subjects with a diagnosis of gastrointestinal disorders to 
cope with the impairment in the quality of life. From this point of view, the 
metacognitive beliefs can play an important role in the experience of the 
disease and in the psychological distress. 
In this perspective, we compared the metacognitive beliefs of three clinical 
groups  with  different  diagnosis.  The  results  did  not  show  significant 
differences between patients with IBS, UC and CD. Besides, there were no 
significant differences for alexithymic features in the three groups. Thus, 
patients  with  different  medical  diagnosis  did  not  show  differences  in 
psychological aspects. Therefore it underlines the importance to consider 
these  aspects  for  care  both  in  patients  with  ‘organic’  and  ‘functional’ 
diagnosis. 
The absence of studies which studied the metacognitive beliefs took us to 
explore  associations  between  metacognitions  and  a  more  investigated 
construct in the literature, that is alexithymia.  
The results showed different associations on the basis of the diagnosis of 
gastrointestinal  disorder.  Regarding  patients  with  IBS,  we  found  a  bond ORGANIC/FUNCTIONAL CATEGORIZATION               MJCP   13 
between the lack of cognitive confidence and the difficulty in identifying 
feelings  and  distinguishing  between  feelings  and  somatic  sensations  of 
emotional arousal. This alexithymic feature showed an inverse association 
with  the  need  to  control  thoughts.  Besides,  the  negative  beliefs  about 
thoughts concerning the need for control showed an inverse association with 
another alexithymic features, that is externally-oriented thinking. Moderate 
correlation  coefficients  highlighted  that  there  were  other  variables  that 
influence these associations. 
Results of the clinical group with IBS showed associations. We registered a 
very strong association between the lack of cognitive confidence and the 
difficulty  in  identifying  feelings  and  distinguishing  between  feelings  and 
somatic sensations of emotional arousal. Moreover, this alexithymic feature 
was  associated  with  negative  beliefs  about  worry  concerning 
uncontrollability and danger. 
Instead, cognitive self-consciousness’ domain of metacognitive beliefs and 
the positive beliefs about worry did not show any relation with alexithymic 
features. 
Regarding patients with UC, the absence of significant correlations between 
alexithymic features and dysfunctional metacognitive beliefs, on the hand, 
and no significant differences with other groups for these variables, on the 
other  hand, need a more systematic study to clarify these results.  
The results of the current study highlight the role of metacognitions in a 
field  where  there  is  a  little  mole  of  research,  that  is  the  gastrointestinal 
disorders  area.  We  underline  the  weight  of  specific  dysfunctional 
metacognitive  beliefs  in  this  clinical  population  and  the  importance  to 
consider the associations on the basis of the diagnosis. These findings can 
be  very  useful  in  the  possibility  to  have  more  efficacious  and  tailored 
treatments for these patients.  
A more detailed analysis of data is, however, necessary to find out the role 
of metacognitions in the field of gastrointestinal disorders, comparing these 
results to normal populations. Research of this kind is currently in progress 
by the authors. 
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